Martin joined AstraZeneca in 2008 and is currently Director of Science Occupation within AstraZeneca’s Transition team. Martin has responsibility for the planning for the move of all Scientific functions into AstraZeneca’s new R&D HQ on the Cambridge Biomedical Campus.
Martin’s career has spanned over 20 years working within the Pharmaceutical industry including varying leadership roles within Procurement, Site & Scientific Operations for organisations such as the Eastern Region Biotech Industry Association (ERBI), Millennium Pharmaceuticals, Pfizer and Warner Lambert.
November 14, 2019
- 10:50 amKeynote Panel: Building and using the Lab of the Future